Literature DB >> 16437732

Remission of bronchial asthma after viral clearance in chronic hepatitis C.

Norihiko Yamamoto1, Kazumoto Murata, Takeshi Nakano.   

Abstract

A 53-year-old man with a history of blood transfusion at the age of 20 was admitted to our hospital because of liver dysfunction. He had bronchial asthma when he was 18 years old, which naturally resolved within 2 years. However, his bronchial asthma recurred at the age of 45 and was treated with oral theophylline. He was diagnosed as having chronic hepatitis C based on the histological and clinical findings, and then interferon (IFN) therapy was administered. The frequency of bronchial asthma attack was gradually decreasing after IFN therapy with marked improvement of hypereosinophilia. He achieved sustained viral response (SVR) and his bronchial asthma did not worsen even after the cessation of IFN. Hepatitis C virus (HCV) infection and IFN therapy were considered in the remission of asthma in this case. HCV infection could be the cause of bronchial asthma, especially in patients with late appearance of asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437732      PMCID: PMC4725173          DOI: 10.3748/wjg.v11.i47.7545

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  Adenovirus E1A upregulates interleukin-8 expression induced by endotoxin in pulmonary epithelial cells.

Authors:  N Keicho; W M Elliott; J C Hogg; S Hayashi
Journal:  Am J Physiol       Date:  1997-06

2.  Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C.

Authors:  E J Bini; E H Weinshel
Journal:  Mayo Clin Proc       Date:  1999-04       Impact factor: 7.616

3.  Cytokine production by T-cell clones from bronchoalveolar lavage fluid of patients with asthma and healthy subjects.

Authors:  F H Krouwels; B E Hol; B Bruinier; R Lutter; H M Jansen; T A Out
Journal:  Eur Respir J Suppl       Date:  1996-08

4.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection: a preliminary study.

Authors:  Hiroshi Kanazawa; Takashi Mamoto; Kazuto Hirata; Junichi Yoshikawa
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

6.  Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response.

Authors:  Massimo Pilli; Amalia Penna; Alessandro Zerbini; Paolo Vescovi; Maddalena Manfredi; Francesco Negro; Marco Carrozzo; Cristina Mori; Tiziana Giuberti; Carlo Ferrari; Gabriele Missale
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

7.  Extrahepatic manifestations of hepatitis C among United States male veterans.

Authors:  Hashem B El-Serag; Howard Hampel; Christine Yeh; Linda Rabeneck
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

8.  Inhaled natural human interferon alpha induces bronchospastic reactions in asthmatics.

Authors:  M Krasnowska; J Małolepszy; E Liebhart; A D Inglot
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1992       Impact factor: 4.291

Review 9.  Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations.

Authors:  S C Gumber; S Chopra
Journal:  Ann Intern Med       Date:  1995-10-15       Impact factor: 25.391

  9 in total
  1 in total

Review 1.  Interferon at the crossroads of allergy and viral infections.

Authors:  Sarah R Gonzales-van Horn; J David Farrar
Journal:  J Leukoc Biol       Date:  2015-05-29       Impact factor: 4.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.